145 related articles for article (PubMed ID: 1490879)
1. Pneumocandins from Zalerion arboricola. IV. Biological evaluation of natural and semisynthetic pneumocandins for activity against Pneumocystis carinii and Candida species.
Schmatz DM; Abruzzo G; Powles MA; McFadden DC; Balkovec JM; Black RM; Nollstadt K; Bartizal K
J Antibiot (Tokyo); 1992 Dec; 45(12):1886-91. PubMed ID: 1490879
[TBL] [Abstract][Full Text] [Related]
2. Pneumocandins from Zalerion arboricola. I. Discovery and isolation.
Schwartz RE; Sesin DF; Joshua H; Wilson KE; Kempf AJ; Goklen KA; Kuehner D; Gailliot P; Gleason C; White R
J Antibiot (Tokyo); 1992 Dec; 45(12):1853-66. PubMed ID: 1490876
[TBL] [Abstract][Full Text] [Related]
3. Pneumocandins from Zalerion arboricola. III. Structure elucidation.
Hensens OD; Liesch JM; Zink DL; Smith JL; Wichmann CF; Schwartz RE
J Antibiot (Tokyo); 1992 Dec; 45(12):1875-85. PubMed ID: 1490878
[TBL] [Abstract][Full Text] [Related]
4. Pneumocandins from Zalerion arboricola. II. Modification of product spectrum by mutation and medium manipulation.
Masurekar PS; Fountoulakis JM; Hallada TC; Sosa MS; Kaplan L
J Antibiot (Tokyo); 1992 Dec; 45(12):1867-74. PubMed ID: 1490877
[TBL] [Abstract][Full Text] [Related]
5. New semisynthetic pneumocandins with improved efficacies against Pneumocystis carinii in the rat.
Schmatz DM; Powles MA; McFadden D; Nollstadt K; Bouffard FA; Dropinski JF; Liberator P; Andersen J
Antimicrob Agents Chemother; 1995 Jun; 39(6):1320-3. PubMed ID: 7574523
[TBL] [Abstract][Full Text] [Related]
6. Pneumocandin D0, a new antifungal agent and potent inhibitor of Pneumocystis carinii.
Morris SA; Schwartz RE; Sesin DF; Masurekar P; Hallada TC; Schmatz DM; Bartizal K; Hensens OD; Zink DL
J Antibiot (Tokyo); 1994 Jul; 47(7):755-64. PubMed ID: 8071120
[TBL] [Abstract][Full Text] [Related]
7. Use of beta-1,3-glucan-specific antibody to study the cyst wall of Pneumocystis carinii and effects of pneumocandin B0 analog L-733,560.
Nollstadt KH; Powles MA; Fujioka H; Aikawa M; Schmatz DM
Antimicrob Agents Chemother; 1994 Oct; 38(10):2258-65. PubMed ID: 7840554
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Pneumocystis carinii pneumonia with 1,3-beta-glucan synthesis inhibitors.
Schmatz DM; Romancheck MA; Pittarelli LA; Schwartz RE; Fromtling RA; Nollstadt KH; Vanmiddlesworth FL; Wilson KE; Turner MJ
Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5950-4. PubMed ID: 2198575
[TBL] [Abstract][Full Text] [Related]
9. In vitro antifungal activities and in vivo efficacies of 1,3-beta-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandin.
Bartizal K; Abruzzo G; Trainor C; Krupa D; Nollstadt K; Schmatz D; Schwartz R; Hammond M; Balkovec J; Vanmiddlesworth F
Antimicrob Agents Chemother; 1992 Aug; 36(8):1648-57. PubMed ID: 1416847
[TBL] [Abstract][Full Text] [Related]
10. In vitro evaluation of the pneumocandin antifungal agent L-733560, a new water-soluble hybrid of L-705589 and L-731373.
Bartizal K; Scott T; Abruzzo GK; Gill CJ; Pacholok C; Lynch L; Kropp H
Antimicrob Agents Chemother; 1995 May; 39(5):1070-6. PubMed ID: 7625791
[TBL] [Abstract][Full Text] [Related]
11. Treatment and prevention of Pneumocystis carinii pneumonia and further elucidation of the P. carinii life cycle with 1,3-beta-glucan synthesis inhibitor L-671,329.
Schmatz DM; Powles M; McFadden DC; Pittarelli LA; Liberator PA; Anderson JW
J Protozool; 1991; 38(6):151S-153S. PubMed ID: 1818147
[TBL] [Abstract][Full Text] [Related]
12. Pneumocandins from Zalerion arboricola. V. Glutamic acid- and leucine-derived amino acids in pneumocandin A0 (L-671,329) and distinct origins of the substituted proline residues in pneumocandins A0 and B0.
Adefarati AA; Hensens OD; Jones ET; Tkacz JS
J Antibiot (Tokyo); 1992 Dec; 45(12):1953-7. PubMed ID: 1362720
[No Abstract] [Full Text] [Related]
13. New model of oropharyngeal and gastrointestinal colonization by Candida albicans in CD4+ T-cell-deficient mice for evaluation of antifungal agents.
Flattery AM; Abruzzo GK; Gill CJ; Smith JG; Bartizal K
Antimicrob Agents Chemother; 1996 Jul; 40(7):1604-9. PubMed ID: 8807048
[TBL] [Abstract][Full Text] [Related]
14. FR131535, a novel water-soluble echinocandin-like lipopeptide: synthesis and biological properties.
Fujie A; Iwamoto T; Sato B; Muramatsu H; Kasahara C; Furuta T; Hori Y; Hino M; Hashimoto S
Bioorg Med Chem Lett; 2001 Feb; 11(3):399-402. PubMed ID: 11212120
[TBL] [Abstract][Full Text] [Related]
15. Characterization of echinocandin-resistant mutants of Candida albicans: genetic, biochemical, and virulence studies.
Kurtz MB; Abruzzo G; Flattery A; Bartizal K; Marrinan JA; Li W; Milligan J; Nollstadt K; Douglas CM
Infect Immun; 1996 Aug; 64(8):3244-51. PubMed ID: 8757860
[TBL] [Abstract][Full Text] [Related]
16. FR901469, a novel antifungal antibiotic from an unidentified fungus No.11243. II. In vitro and in vivo activities.
Fujie A; Iwamoto T; Muramatsu H; Okudaira T; Sato I; Furuta T; Tsurumi Y; Hori Y; Hino M; Hashimoto S; Okuhara M
J Antibiot (Tokyo); 2000 Sep; 53(9):920-7. PubMed ID: 11099225
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of MK-991 (L-743,872), a semisynthetic pneumocandin, in murine models of Pneumocystis carinii.
Powles MA; Liberator P; Anderson J; Karkhanis Y; Dropinski JF; Bouffard FA; Balkovec JM; Fujioka H; Aikawa M; McFadden D; Schmatz D
Antimicrob Agents Chemother; 1998 Aug; 42(8):1985-9. PubMed ID: 9687394
[TBL] [Abstract][Full Text] [Related]
18. Increased antifungal activity of L-733,560, a water-soluble, semisynthetic pneumocandin, is due to enhanced inhibition of cell wall synthesis.
Kurtz MB; Douglas C; Marrinan J; Nollstadt K; Onishi J; Dreikorn S; Milligan J; Mandala S; Thompson J; Balkovec JM
Antimicrob Agents Chemother; 1994 Dec; 38(12):2750-7. PubMed ID: 7695257
[TBL] [Abstract][Full Text] [Related]
19. Cell wall assembly by Pneumocystis carinii. Evidence for a unique gsc-1 subunit mediating beta -1,3-glucan deposition.
Kottom TJ; Limper AH
J Biol Chem; 2000 Dec; 275(51):40628-34. PubMed ID: 11013231
[TBL] [Abstract][Full Text] [Related]
20. Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase.
Kurtz MB; Heath IB; Marrinan J; Dreikorn S; Onishi J; Douglas C
Antimicrob Agents Chemother; 1994 Jul; 38(7):1480-9. PubMed ID: 7979276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
